British American Tobacco's Q4 2024 results highlight smokeless product growth, innovation, and financial resilience.

British American Tobacco sales fall as ‘illicit single-use’ vapes hamper trading - Shares fell as much 9% as it revealed a slight decline in US vape sales, which it has touted as the future of the ...

New categories products--which includes vapour/heated products and oral pouches--revenue rose 2.5% to 3.42 billion pounds from 3.26 billion pounds, below market consensus of 3.50 billion pounds. The ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...

Last month, the FDA authorized the sale of 10 Zyn flavors, marking the first time the agency has backed the public health ...

Wall Street drifted through a mixed day of trading as rising fashion and cigarette stocks worked against drops for Ford Motor ...

In June 2018, then-health minister Steve Brine wrote to the company ... government's landmark Tobacco and Vapes Bill will enhance existing legislation, including on advertising, and put us on ...